In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine

Kohler, L. M.; Monteiro, P. C. F.; Hahn, R. C.; Hamdan, J. S.

Article

Registro en:

KOHLER, Lidiane Meire et al. In Vitro Susceptibilities of Isolates of Sporothrix schenckii to itraconazole and terbinafine. Journal of Clinical Microbiology, v. 42, n. 9, p. 4319-4320, Sept. 2004.

0095-1137

https://www.arca.fiocruz.br/handle/icict/32962

10.1128/JCM.42.9.4319-4320.2004

1098-660X

https://repositorioslatinoamericanos.uchile.cl/handle/2250/8861955

Autor

Kohler, L. M.

Monteiro, P. C. F.

Hahn, R. C.

Hamdan, J. S.

Institución

Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (Brasil)

Resumen

Thirty isolates of the yeast form of Sporothrix schenckii were evaluated for in vitro susceptibility to itraconazole and terbinafine by the recommended NCCLS modified technique (M27-A2). The MICs of itraconazole obtained oscillated between 0.062 and 4.0 g/ml, and those of terbinafine oscillated between 0.007 and 0.50 g/ml; therefore, terbinafine showed greater in vitro activity.

2019-11-06

Materias

Sporothrix schenckii

Itraconazole

Terbinafine

Mostrar el registro completo del ítem